Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | São Paulo medical journal (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802014000600359 |
Resumo: | CONTEXT AND OBJECTIVE: Occurrences of asymptomatic atrial fibrillation (AF) are common. It is important to identify AF because it increases morbidity and mortality. 24-hour Holter has been used to detect paroxysmal AF (PAF). The objective of this study was to investigate the relationship between occurrence of PAF in 24-hour Holter and the symptoms of the population studied.DESIGN AND SETTING: Cross-sectional study conducted at a cardiology hospital.METHODS: 11,321 consecutive 24-hour Holter tests performed at a referral service were analyzed. Patients with pacemakers or with AF throughout the recording were excluded.RESULTS: There were 75 tests (0.67%) with PAF. The mean age was 67 ± 13 years and 45% were female. The heart rate (HR) over the 24 hours was a minimum of 45 ± 8 bpm, mean of 74 ± 17 bpm and maximum of 151 ± 32 bpm. Among the tests showing PAF, only 26% had symptoms. The only factor tested that showed a correlation with symptomatic AF was maximum HR (165 ± 34 versus 147 ± 30 bpm) (P = 0.03). Use of beta blockers had a protective effect against occurrence of PAF symptoms (odds ratio: 0.24, P = 0.031).CONCLUSIONS: PAF is a rare event in 24-hour Holter. The maximum HR during the 24 hours was the only factor correlated with symptomatic AF, and use of beta blockers had a protective effect against AF symptom occurrence. |
id |
APM-1_4f96ace185afb806f3afc5ca7d3cfb5d |
---|---|
oai_identifier_str |
oai:scielo:S1516-31802014000600359 |
network_acronym_str |
APM-1 |
network_name_str |
São Paulo medical journal (Online) |
repository_id_str |
|
spelling |
Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional studyAtrial fibrillationSigns and symptomsElectrocardiography, ambulatoryArrhythmias, cardiacElectrophysiologyCONTEXT AND OBJECTIVE: Occurrences of asymptomatic atrial fibrillation (AF) are common. It is important to identify AF because it increases morbidity and mortality. 24-hour Holter has been used to detect paroxysmal AF (PAF). The objective of this study was to investigate the relationship between occurrence of PAF in 24-hour Holter and the symptoms of the population studied.DESIGN AND SETTING: Cross-sectional study conducted at a cardiology hospital.METHODS: 11,321 consecutive 24-hour Holter tests performed at a referral service were analyzed. Patients with pacemakers or with AF throughout the recording were excluded.RESULTS: There were 75 tests (0.67%) with PAF. The mean age was 67 ± 13 years and 45% were female. The heart rate (HR) over the 24 hours was a minimum of 45 ± 8 bpm, mean of 74 ± 17 bpm and maximum of 151 ± 32 bpm. Among the tests showing PAF, only 26% had symptoms. The only factor tested that showed a correlation with symptomatic AF was maximum HR (165 ± 34 versus 147 ± 30 bpm) (P = 0.03). Use of beta blockers had a protective effect against occurrence of PAF symptoms (odds ratio: 0.24, P = 0.031).CONCLUSIONS: PAF is a rare event in 24-hour Holter. The maximum HR during the 24 hours was the only factor correlated with symptomatic AF, and use of beta blockers had a protective effect against AF symptom occurrence.Associação Paulista de Medicina - APM2014-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802014000600359Sao Paulo Medical Journal v.132 n.6 2014reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/1516-3180.2014.1326732info:eu-repo/semantics/openAccessKruse,Marcelo LapaKruse,José Cláudio LupiLeiria,Tiago Luiz LuzPires,Leonardo MartinsGensas,Caroline SaltzGomes,Daniel GarciaBoris,DouglasMantovani,AugustoLima,Gustavo Glotz deeng2015-09-29T00:00:00Zoai:scielo:S1516-31802014000600359Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2015-09-29T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse |
dc.title.none.fl_str_mv |
Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional study |
title |
Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional study |
spellingShingle |
Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional study Kruse,Marcelo Lapa Atrial fibrillation Signs and symptoms Electrocardiography, ambulatory Arrhythmias, cardiac Electrophysiology |
title_short |
Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional study |
title_full |
Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional study |
title_fullStr |
Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional study |
title_full_unstemmed |
Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional study |
title_sort |
Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional study |
author |
Kruse,Marcelo Lapa |
author_facet |
Kruse,Marcelo Lapa Kruse,José Cláudio Lupi Leiria,Tiago Luiz Luz Pires,Leonardo Martins Gensas,Caroline Saltz Gomes,Daniel Garcia Boris,Douglas Mantovani,Augusto Lima,Gustavo Glotz de |
author_role |
author |
author2 |
Kruse,José Cláudio Lupi Leiria,Tiago Luiz Luz Pires,Leonardo Martins Gensas,Caroline Saltz Gomes,Daniel Garcia Boris,Douglas Mantovani,Augusto Lima,Gustavo Glotz de |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Kruse,Marcelo Lapa Kruse,José Cláudio Lupi Leiria,Tiago Luiz Luz Pires,Leonardo Martins Gensas,Caroline Saltz Gomes,Daniel Garcia Boris,Douglas Mantovani,Augusto Lima,Gustavo Glotz de |
dc.subject.por.fl_str_mv |
Atrial fibrillation Signs and symptoms Electrocardiography, ambulatory Arrhythmias, cardiac Electrophysiology |
topic |
Atrial fibrillation Signs and symptoms Electrocardiography, ambulatory Arrhythmias, cardiac Electrophysiology |
description |
CONTEXT AND OBJECTIVE: Occurrences of asymptomatic atrial fibrillation (AF) are common. It is important to identify AF because it increases morbidity and mortality. 24-hour Holter has been used to detect paroxysmal AF (PAF). The objective of this study was to investigate the relationship between occurrence of PAF in 24-hour Holter and the symptoms of the population studied.DESIGN AND SETTING: Cross-sectional study conducted at a cardiology hospital.METHODS: 11,321 consecutive 24-hour Holter tests performed at a referral service were analyzed. Patients with pacemakers or with AF throughout the recording were excluded.RESULTS: There were 75 tests (0.67%) with PAF. The mean age was 67 ± 13 years and 45% were female. The heart rate (HR) over the 24 hours was a minimum of 45 ± 8 bpm, mean of 74 ± 17 bpm and maximum of 151 ± 32 bpm. Among the tests showing PAF, only 26% had symptoms. The only factor tested that showed a correlation with symptomatic AF was maximum HR (165 ± 34 versus 147 ± 30 bpm) (P = 0.03). Use of beta blockers had a protective effect against occurrence of PAF symptoms (odds ratio: 0.24, P = 0.031).CONCLUSIONS: PAF is a rare event in 24-hour Holter. The maximum HR during the 24 hours was the only factor correlated with symptomatic AF, and use of beta blockers had a protective effect against AF symptom occurrence. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802014000600359 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802014000600359 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1516-3180.2014.1326732 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Paulista de Medicina - APM |
publisher.none.fl_str_mv |
Associação Paulista de Medicina - APM |
dc.source.none.fl_str_mv |
Sao Paulo Medical Journal v.132 n.6 2014 reponame:São Paulo medical journal (Online) instname:Associação Paulista de Medicina instacron:APM |
instname_str |
Associação Paulista de Medicina |
instacron_str |
APM |
institution |
APM |
reponame_str |
São Paulo medical journal (Online) |
collection |
São Paulo medical journal (Online) |
repository.name.fl_str_mv |
São Paulo medical journal (Online) - Associação Paulista de Medicina |
repository.mail.fl_str_mv |
revistas@apm.org.br |
_version_ |
1754209263989817344 |